ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $99,308 | -29.3% | 14,800 | -6.9% | 0.00% | – |
| Q1 2023 | $140,397 | -48.5% | 15,900 | -55.5% | 0.00% | -100.0% |
| Q4 2022 | $272,748 | -25.1% | 35,700 | -30.1% | 0.00% | 0.0% |
| Q3 2022 | $364,000 | -2.9% | 51,100 | +10.1% | 0.00% | 0.0% |
| Q2 2022 | $375,000 | +123.2% | 46,400 | +283.5% | 0.00% | – |
| Q1 2022 | $168,000 | -88.3% | 12,100 | -66.0% | 0.00% | -100.0% |
| Q1 2021 | $1,433,000 | – | 35,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |